trial · primary record
Biospecimen Collection
Advanced Cervical Adenocarcinoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 21 |
| Primary completion | 2027-04-29 |
| Primary endpoint | Maximum Tolerated Dose (MTD) |
| Registry ID | NCT02595879 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:15.152Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02595879
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Biospecimen Collection · compound